RPRX Royalty Pharma plc
Price Chart
Executive Summary
Two insiders at Royalty Pharma sold a combined $888K in open-market sales on May 14, 2026, following the company's Q1 earnings beat and raised guidance reported on May 6. The sales are small relative to the $30.7B market cap (0.003%) and likely reflect routine portfolio diversification after a strong earnings release, not a bearish signal.
Key Financial Metrics
Actionable Insight
The insider sales are negligible in size and follow a strong earnings report, suggesting no negative read-through. Monitor for any larger insider sales in the coming weeks, but this cluster alone does not warrant action.
Key Facts
- EVP Urist Marshall sold 13,684 shares at ~$53.06 for $726K on May 14, 2026.
- Director Norden Gregory sold 3,045 shares at $53.00 for $161K on May 14, 2026.
- Total insider sales of $888K represent ~0.003% of RPRX's $30.7B market cap.
- Sales occurred 8 days after RPRX reported Q1 2026 Portfolio Receipts of $925M (+10% YoY) and raised full-year guidance.
- No open-market purchases were reported in the cluster.
Financial Impact
Total insider sales of $888K, immaterial relative to $30.7B market cap.
Risk Factors
- Insider sales could accelerate if the stock continues to appreciate post-earnings.
- No purchases in the cluster provide no bullish signal from insiders.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RPRX-1778877697570 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
12d ago
|
Insider Cluster
| $55.76 $55.87 | ▲ +0.20% | ▲ +2.72% | $54.86 (−1.61%) |
|
May 28, 2026
12d ago
|
8-K
| $55.76 $54.97 | ▼ −1.42% | ▼ −1.12% | $54.86 (−1.61%) |
|
May 22, 2026
19d ago
|
Insider Cluster
| $54.50 $55.18 | ▲ +1.25% | ▼ −0.41% | $54.86 (+0.66%) |
|
May 15, 2026
25d ago
|
Insider Cluster
| $52.07 $53.86 | ▲ +3.44% | ▲ +1.82% | $54.86 (+5.36%) |
|
May 14, 2026
26d ago
|
144
| $52.85 $54.50 | ▲ +3.12% | ▲ +2.16% | $54.86 (+3.80%) |
|
May 6, 2026
4w ago
|
8-K
| $50.72 $51.70 | ▲ +1.93% | ▲ +0.80% | $54.86 (+8.16%) |
|
Apr 17, 2026
7w ago
|
Press Release
| $50.00 $49.38 | ▼ −1.24% | ▼ −1.79% | $54.86 (+9.72%) |
|
Apr 15, 2026
7w ago
|
Press Release
| $48.48 $49.64 | ▲ +2.39% | ▲ +1.41% | $54.86 (+13.16%) |
|
Apr 10, 2026
8w ago
|
DEFA14A
| $48.43 $49.30 | ▲ +1.80% | ▼ −1.50% | $54.86 (+13.28%) |
|
Mar 30, 2026
10w ago
|
Press Release
| $46.37 $46.87 | ▲ +1.08% | ▼ −3.22% | $54.86 (+18.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access